Financials Naturhouse Health, S.A.

Equities

NTH

ES0105043006

Other Specialty Retailers

Market Closed - BME 11:35:10 2024-04-30 am EDT 5-day change 1st Jan Change
1.67 EUR +0.30% Intraday chart for Naturhouse Health, S.A. -.--% +3.09%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 119.7 92.92 115.4 94.42 97.12 100.1 - -
Enterprise Value (EV) 1 119.7 92.92 92.52 84.43 97.12 77.12 75.12 74.02
P/E ratio - - 8.75 x 9.84 x 8.53 x 9.82 x 9.82 x 9.82 x
Yield - - 3.12% 9.52% - 8.38% 8.38% 8.38%
Capitalization / Revenue 1.47 x 1.69 x 2 x 1.8 x 1.93 x 2 x 1.96 x 1.91 x
EV / Revenue 1.47 x 1.69 x 1.61 x 1.61 x 1.93 x 1.54 x 1.47 x 1.41 x
EV / EBITDA 5.21 x 5.64 x 4.67 x 5.37 x - 4.73 x 4.55 x 4.46 x
EV / FCF - - 5.74 x 13.8 x - 8.03 x 7.99 x 7.71 x
FCF Yield - - 17.4% 7.26% - 12.4% 12.5% 13%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 59,950 59,949 59,949 59,949 59,949 59,949 - -
Reference price 2 1.996 1.550 1.925 1.575 1.620 1.670 1.670 1.670
Announcement Date 2/28/20 3/1/21 2/28/22 2/28/23 3/15/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 81.67 55.08 57.59 52.4 50.41 50 51 52.4
EBITDA 1 22.98 16.48 19.8 15.72 - 16.3 16.5 16.6
EBIT 1 18.69 13.22 17.34 12.85 16.26 14.1 14.3 14.3
Operating Margin 22.89% 24.01% 30.1% 24.53% 32.27% 28.2% 28.04% 27.29%
Earnings before Tax (EBT) 1 - - 18.24 13.1 15.42 14.1 14.3 14.4
Net income 1 - - 13.36 9.627 11.29 10.3 10.5 10.5
Net margin - - 23.2% 18.37% 22.4% 20.6% 20.59% 20.04%
EPS 2 - - 0.2200 0.1600 0.1900 0.1700 0.1700 0.1700
Free Cash Flow 1 - - 16.12 6.133 - 9.6 9.4 9.6
FCF margin - - 27.99% 11.7% - 19.2% 18.43% 18.32%
FCF Conversion (EBITDA) - - 81.45% 39.02% - 58.9% 56.97% 57.83%
FCF Conversion (Net income) - - 120.67% 63.71% - 93.2% 89.52% 91.43%
Dividend per Share 2 - - 0.0600 0.1500 - 0.1400 0.1400 0.1400
Announcement Date 2/28/20 3/1/21 2/28/22 2/28/23 3/15/24 - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 - - 22.9 9.99 - 23 25 26.1
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - - 16.1 6.13 - 9.6 9.4 9.6
ROE (net income / shareholders' equity) - - 43% 30.1% - 32.9% 31.3% 29.2%
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 - - 0.05 0.96 - 0.6 0.6 0.6
Capex / Sales - - 0.09% 1.84% - 1.2% 1.18% 1.15%
Announcement Date 2/28/20 3/1/21 2/28/22 2/28/23 3/15/24 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
1
Last Close Price
1.67
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NTH Stock
  4. Financials Naturhouse Health, S.A.